Adrenal disorders encompass a wide spectrum of diseases, each with its unique pathophysiology, clinical presentation, and management strategies. This article aims to provide a comprehensive overview of these disorders, highlighting key points for diagnosis and treatment.
The adrenal glands, located superior to the kidneys, consist of two distinct parts: the cortex and medulla. Each part produces different hormones essential for maintaining homeostasis. The cortex produces glucocorticoids, mineralocorticoids, and adrenal androgens, while the medulla secretes catecholamines.
Adrenal insufficiency occurs when the adrenal glands cannot produce sufficient hormones. It can be primary (Addison's disease), secondary due to pituitary dysfunction, or tertiary due to hypothalamic disease. Symptoms are often nonspecific, including fatigue, weight loss, and hypotension. Diagnosis involves baseline cortisol measurement and dynamic testing. Treatment typically involves hormone replacement.
Cushing syndrome is characterized by excess cortisol, leading to weight gain, hypertension, diabetes, and osteoporosis. It can be endogenous (due to adrenal, pituitary, or ectopic tumors) or exogenous (prolonged glucocorticoid use). Diagnosis involves screening tests, such as 24-hour urinary free cortisol, followed by confirmatory tests. Treatment depends on the underlying cause.
Adrenal incidentalomas are adrenal masses discovered incidentally during imaging studies performed for unrelated reasons. Although most are benign and nonfunctional, they require evaluation to rule out malignancy and hormone hypersecretion. Management varies based on size, imaging characteristics, and functionality.
Pheochromocytomas and paragangliomas are rare catecholamine-secreting tumors that can cause severe hypertension. Diagnosis involves biochemical testing for metanephrines, followed by imaging. Surgical resection is the treatment of choice.
Understanding adrenal disorders is crucial for accurate diagnosis and effective management. While some disorders are common and others rare, all require a high index of suspicion, appropriate testing, and individualized treatment strategies. As our understanding of these disorders continues to evolve, so too will our approach to patient care.
1.
Combo Therapy Boosts Early CML Response but Not Long Term
2.
PNH With Extravascular Hemolysis Approves Factor D Inhibitor.
3.
In a long-term comparison with adjuvant RT, salvage radiotherapy after prostateectomy is the most successful treatment.
4.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
5.
Classifying childhood brain cancers by immune response may improve diagnostics and treatments
1.
Precision Oncology: Integrating Genomics and Data to Shape Cancer Care’s Future
2.
Decoding Hamartomas: Understanding Their Causes and Symptoms
3.
Understanding the Silent Threat: Unveiling Prostate Cancer Symptoms
4.
Battling Blood Cancers: Advances in HIV-Related Hematologic Malignancies in the ART Era
5.
Breaking Barriers: Innovative Approaches in Brain Tumor Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
3.
Efficient Management of First line ALK-rearranged NSCLC
4.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation